2009-07-03 | Medical News Today

Pain Medicine Experts Recommend Safe And Responsible Use Of Acetaminophen

In response to the advisory committee's recommendations to the U.S. Food and Drug Administration (FDA) to put new restrictions on acetaminophen this week, physician leaders from the American Academy of Pain Medicine (AAPM), have released the following statement:

2009-07-02 | Med Compare

Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen

Source: American Academy of Pain Medicine In response to the advisory committee's recommendations to the U.S. Food and Drug Administration (FDA) to put new restrictions on acetaminophen this week, physician leaders from the American Academy of Pain Medicine (AAPM), have released the following statement: The..

2009-07-02 | ScoutNews, LLC

If 2 Painkillers Are Banned, What Next?

THURSDAY, July 2 (HealthDay News) -- Banning the popular painkillers Percocet and Vicodin, which a U.S. health advisory panel has urged, would not be as drastic as it sounds, some medical experts contend.

2009-07-01 | Newsweek Blogs

OTC FAQs: The Real-Life Realities Behind the FDA's New Recommendations

A Food and Drug Administration advisory panel voted yesterday to lower the recommended dose of over-the-counter acetaminophen, the controversial ingredient in popular painkillers like Tylenol and Excedrin.

2009-07-01 | Pharmacy Choice

6/30/09 - FDA panel recommends smaller doses of painkillers

ADELPHI, Md.-Government experts say the maximum dose listed for Tylenol and dozens of other painkillers should be reduced to help curb deadly overdoses.

2009-06-30 | New York Times

Ban Is Advised on 2 Top Pills for Pain Relief

ADELPHI, Md. A federal advisory panel voted narrowly on Tuesday to recommend a ban on Percocet and Vicodin, two of the most popular prescription painkillers in the world, because of their effects on the liver.

2009-06-30 | The Salt Lake Tribune

Forty lives saved from ODs: Cheap at twice the price

What's the value of a human life? No one can answer this age-old question, but thanks to the efforts of the Utah Department of Health, many volunteer health professionals and the state Legislature, we have learned how much it costs to save a life.

2009-06-25 | PharmaLive

Pfizer and Eli Lilly Address Safety and Transparency

In September, two of the largest pharmaceutical companies used the Internet to take new steps in safety and transparency.

2009-06-19 | Modern Medicine

Oxygen-Ozone Injections May Help Lower Back Pain

Intramuscular paravertebral injections linked to pain relief, lower intake of analgesic...

2009-06-19 | Modern Medicine

Advances Seen in Biologic Therapies for Disk Disease

But more research is needed before molecular, gene and cell-based therapies become...

2009-06-19 | Newswise

Spinal Cord Stimulation for Pain Problems May Allow Soldiers to Be Deployed

Electrical spinal cord stimulation (SCS) provides an option for military personnel with back pain and other chronic pain conditionsin appropriate cases, allowing soldiers to return to combat and other strenuous duties, according to a study in the July issue of Anesthesia & Analgesia, official journal of the.

2009-06-18 | Associated Press / NBC Miami

Crist Puts the Cap on Pill Popping

Gov. Charlie Crist signed a new law Thursday that will set up a prescription drug tracking system designed to reduce, if not end, Florida's role as the nation's leading supplier of drugs for illicit purposes.

2009-06-17 | Modern Medicine

Spinal Approaches Linked to Similar Pain Outcomes

Study compared percutaneous vertebroplasty, conservative treatment in osteoporotic...

2009-06-17 | PR Newswire

Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules

/PRNewswire/ -- Xanodyne Pharmaceuticals, Inc. announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for Zipsor (diclofenac potassium) Liquid Filled Capsules, a new treatment option indicated for relief of mild to moderate acute pain in adults (18 years of age or...

2009-06-17 | PhysOrg.com

Study Pinpoints Links of Depression with Chronic Pain

June 17th, 2009 It is well known that chronic pain and clinical depression go together, but a study in The Journal of Pain, published by the American Pain Society, shows that the connection between pain and depression is strongest in middle-age women and African Americans.

2009-06-17 | Pharmacy Choice

6/16/09 - Nuvo, Covidien ink US license and development agreement for Pennsaid and Pennsaid Plus

16 June 2009 - Canada-based drug maker Nuvo Research Inc (TSE: NRI) said today (16 June) it has signed a license and development agreement with Mallinckrodt Inc, a subsidiary of Ireland-based Covidien (NYSE: COV), granting it exclusive rights to market and sell Pennsaid, and its follow-on product, Pennsaid...

2009-06-16 | NewsChannel 8

Less-invasive Treatment Helps Back Pain Sufferers

WASHINGTON - Eight out of 10 Americans will suffer from back pain at some point in their lives. The pain is sometimes so severe, it requires surgery and months of rehabilitation -- but there are other options.

2009-06-16 | Modern Medicine

Discoblock Effective for Back Pain Diagnosis

Patients who experience pain relief after discoblock have better outcomes after...

2009-06-16 | EurekAlert!

Peripheral nerve repair with fat precursor cells led to wider nerves and less muscle atrophy

Tampa, Fla. (June 16, 2009) To determine if guided fat (adipose) precursor cells (APCs) could improve nerve regeneration and functional recovery, researchers at the University of Pittsburgh (USA) used biodegradable nerve guides to transplant APCs into the injured peripheral nerves of laboratory rats.

2009-06-16 | Biotechnology Healthcare

Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia

PALO ALTO, Calif., June 15, 2009 /PRNewswire-FirstCall via COMTEX/ -- Jazz Pharmaceuticals' sodium oxybate demonstrated statistically significant and clinically meaningful improvement in pain and the core symptoms associated with fibromyalgia, according to Phase III data presented last week at the 2009...

2009-06-16 | Journal of Pain

Changes in Gray Matter Density in Fibromyalgia: Correlation With Dopamine Metabolism

Fibromyalgia (FM) has been associated with alterations in brain morphometry and abnormal dopaminergic neurotransmission. Evidence from preclinical models has demonstrated that dopamine plays a role in promoting neuronal integrity.

2009-06-15 | Gene Ref

Chemical in blood may explain susceptibility to bladder pain

A marker in the blood of both cats and humans that was identified in a recent study might signal both species' susceptibility for a painful bladder disorder called interstitial cystitis, a condition that is often difficult to diagnose.

2009-06-15 | Biospace

Transdel Pharmaceuticals, Inc. (TDLP.OB) Provides Update on Timing of Results for Phase 3 Study

LA JOLLA, Calif., June 15 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. a specialty pharmaceutical company focused on developing non-invasive, topically administered products, announced that they anticipate reporting top-line results from their current Phase 3 study of Ketotransdel(R) during the...

2009-06-15 | Science Daily

Therapeutic Delivery Of A Gene To Dysfunctional Nerves

In many sensory neuronopathies, painful conditions affecting sensory nerves outside the brain and spinal cord, the affected nerves are in a region known as the DRG.

2009-06-12 | Modern Medicine

Intervention Effective for Workers With Back Pain

Workplace intervention most effective for older workers and those with previous sick...

2009-06-12 | Reuters Markets

UPDATE 1-US FDA cites safety issues with Savient gout drug

* Agency: concerns over heart problems, allergies * FDA to seek advice from panel of advisers Tuesday * Savient says risks manageable with monitoring By Susan Heavey WASHINGTON, June 12 (Reuters) - Savient Pharmaceuticals Inc's (SVNT.

2009-06-11 | Biospace

Pfizer Inc. (PFE)'s (JOBS) Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show

COPENHAGEN--(BUSINESS WIRE)--Pfizer announced today that data from two new mid-stage clinical studies of the companys oral JAK-3 inhibitor, CP-690,550, showed statistically significant response versus placebo for patients with rheumatoid arthritis (RA).

2009-06-11 | Medical News Today

NeurogesX Provides U.S. Regulatory Update For Qutenza(TM)

NeurogesX, Inc. (Nasdaq: NGSX) announced that the U.S. Food and Drug Administration (FDA) agreed to its proposed study to evaluate Qutenza(TM) in patients with post-herpetic neuralgia (PHN) following pretreatment with an FDA-approved topical anesthetic.

2009-06-11 | NewsRx

Common migraine pain condition also prevalent in cluster headache

A pain condition common in people with migraines also has a high prevalence in patients with cluster headache, according to a study conducted by researchers at the Jefferson Headache Center at Jefferson Hospital for Neuroscience.

2009-06-10 | Pharmaceutical Processing

KV Pharmaceutical Company, Purdue Pharma L.P. Settle OxyContin(R) Dispute

KV Pharmaceutical Company of St. Louis, MO., has entered into a settlement agreement with Purdue Pharma L.P. of Stamford, Conn., in regard to the patent infringement lawsuit between the two companies.

2009-06-10 | Genetic Engineering & Biotechnology News

Collegium Pharmaceutical Inc. Announces Submission of a Request for Special Protocol Assessment to FDA for Pivotal Trial for Tamper Resistant, Extended Release Opioid (COL-003)

News source: Business Wire Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has submitted a proposal to the US Food and Drug Administration (FDA) for a Phase III pivotal trial of COL-003 under the Special Protocol Assessment (SPA) process.

2009-06-10 | Press-Telegram (AP)

New back pain treatment technology to get trials at Long Beach Memorial

Video on the technology: LONG BEACH - For some it's a pain in the neck, but for Memorial Medical Center of Long Beach, it may be an opportunity. A new technology that hopes to streamline the treatment of neck and back pain will be tested in clinical trials at the hospital beginning in late July or early...

2009-06-08 | Modern Medicine

Surgery Improves Spondylolisthesis Outcomes

Surgical patients have greater long-term improvements compared to nonoperative...

2009-06-08 | Reuters Markets

UPDATE 1-Lundbeck delays US drug application, shares dive

* New anti-depressant drug application delayed 18-24 months * Phase III trial show insignificant effect vs placebo * Shares fall 16 percent at 1302 GMT (Add detail, company and analyst comments, share price) By Peter Levring COPENHAGEN, June 8 (Reuters) - Drug maker Lundbeck (LUN.

2009-06-08 | Pharmacy Choice

6/8/09 - Phosphagenics Announces Completion of Transdermal Patch Prototypes

2009 JUN 8 - (NewsRx.com) -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system.

2009-06-08 | Genetic Engineering & Biotechnology News

PanGenetics Receives Approval for Clinical Evaluation of Anti-NGF Antibody in Patients with Chronic Pain

News source: Business Wire PanGenetics B.V. announced today that the Competent Authority of the Netherlands has approved the Clinical Trials Application for a first-in-man study with antibody PG110.

2009-06-08 | NewsRx

Investigating the development of mechanosensitivity

(NewsRx.com) -- Researchers of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained crucial insight into how mechanosensitivity arises.

2009-06-08 | Medical News Today

Highlights Of Pain Research

Musculoskeletal problems are among the complaints most frequently reported in health interview surveys.

2009-06-06 | Medical News Today

Ginkgo Reduces Neuropathic Pain In Animal Studies

An extract of ginkgo biloba shows scientific evidence of effectiveness against one common and hard-to-treat type of pain, according to animal data reported in the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

2009-06-06 | DGDispatch

Extended-Release Tapentadol Confers Sustained Improvements in Painful Diabetic Peripheral Neuropathy: Presented at ADA

NEW ORLEANS -- June 6, 2009 -- Patients who respond initially to the investigational extended-release (ER) formulation of tapentadol for the treatment of their diabetic neuropathic pain (DPN) experience ongoing benefit throughout 12 additional weeks of treatment, according to data reported here today at the American Diabetes Association (ADA) 69th Scientific Sessions.

2009-06-05 | Biospace

Some OTC Sleep, Cold Meds Could Harm Aging Brain, Indiana University Study

THURSDAY, June 4 (HealthDay News) --Older people taking common over-the-counter drugs for pain, cold symptoms or help with sleep may increase their risk for cognitive impairment, including delirium, University of Indiana researchers report.

2009-06-05 | The Daily News Journal

Find help for headaches

And this year, as National Headache Week approaches, the National Headache Foundation is urging headache sufferers to take a personal approach to treatment.

2009-06-04 | Med Compare

UPDATE 1-Almirall Gets FDA Approval For Migraine Drug

Source: Reuters Spanish pharmaceutical firm Almirall (ALM.MC) on Wednesday said its Almotriptan migraine drug had gained U.S. Food and Drug Administration approval for adolescents.

2009-06-04 | Reuters Health News

Sedatives may increase elderly suicide risk: study

LONDON (Reuters) - Sedatives and sleeping pills prescribed to ease depression, anxiety and sleep problems appear to increase the risk of suicide four-fold among the elderly, Swedish researchers said on Wednesday.

2009-06-03 | Neurology Today

One Investigator's Fraud Affects the Field of Neurologic Pain Management

ARTICLE IN BRIEF In response to a prominent pain investigator's admission of scientific fraud, leading neurologists who specialize in pain management discuss the ramifications of that admission on current and future research in the field.

2009-06-03 | Biospace

Eli Lilly and Company (LLY) (JOBS) Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

INDIANAPOLIS, June 3 /PRNewswire-FirstCall/ -- As projected, Eli Lilly and Company (NYSE: LLY - News) has resubmitted its supplemental New Drug Application (sNDA) for Cymbalta� (duloxetine HCl) for the management of chronic pain to the U.

2009-06-03 | Med Compare

Study Examines Relationship Between Bone Density And Erosion In Arthritis

Source: Wiley-Blackwell Up to 50 percent of RA patients show evidence of focal erosions, and RA doubles the risk of osteoporosis and fractures Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, affects almost three percent of people over age 65.

2009-06-03 | Congoo

Arthritis Sufferers Experience Reduced Pain With Tai Chi

The results of a new analysis have provided good evidence to suggest that Tai Chi is beneficial for arthritis. Specifically, it was shown to decrease pain with trends towards improving overall physical health, level of tension and satisfaction with health status.

2009-06-03 | Medical News Today

B. Braun Anticipates Becoming First To Deliver FDA Approved 2g Cefazolin

B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, said today it anticipates U.S. Food and Drug Administration (FDA) approval for 2g Cefazolin for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX(R) Drug Delivery System.

2009-06-02 | Science Daily

Exercise More, Not Less, To Ease Aching Back, Study Suggests

People with lower back pain are better off exercising more, not less. A University of Alberta study of 240 men and women with chronic lower-back pain showed that those who exercised four days a week had a better quality of life, 28 per cent less pain and 36 per cent less disability, while those who hit the.

2009-06-02 | Pharma Live

Clinical Data, Inc. Announces Positive Results from Second Phase III Trial of Vilazodone for Depression

- Clinical Data, Inc. (NASDAQ: CLDA) today announced positive top-line results from the second of two Phase III trials of its investigational compound, vilazodone, for the treatment of major depressive disorder (MDD).

2009-06-02 | Science Based Medicine

Adverse Effects of Chiropractic

There is a very good chance that you will feel worse after seeing a chiropractor. According to a new systematic review, serious complications of spinal manipulation are rare, but 33-60% of patients experience milder short-term adverse effects such as increased pain, radiation of pain, headaches, vertigo and..

2009-06-02 | Medical News Today

Managing Acute Post-operative Pain In Hospital

Health professionals caring for patients with acute post-operative pain can improve pain management with a new drug use evaluation toolkit developed by the National Prescribing Service Ltd (NPS).

2009-06-02 | Medical News Today

To What Extent Can Environmental Pollutants And Alcohol Affect GI Health?

New research quantifies the precise effects of environmental pollutants and alcohol intake on gastrointestinal (GI) health. Both studies being presented this week during Digestive Disease Week� 2009 (DDW�) offer concrete evidence that the environment and alcohol intake can affect GI health and share important insights into new directions for future research.

2009-05-29 | NewsRx

Brain chemical reduces anxiety, increases survival of new cells

(NewsRx.com) -- New research on a brain chemical involved in development sheds light on why some individuals may be predisposed to anxiety. It also strengthens understanding of cellular processes that may be common to anxiety and depression, and suggests how lifestyle changes may help overcome both.

2009-05-29 | Reuters Special Coverage News

Vitamin D may help prevent knee osteoarthritis

- Low levels of vitamin D are associated with the loss of cartilage in the knee joint of older individuals, researchers in Australia report. "Cartilage loss is the hallmark of osteoarthritis," Dr.

2009-05-28 | Wall Street Journal Online

UCLA Surgeon Didn't Report Payments

A top spine surgeon at the University of California, Los Angeles failed to disclose payments from medical companies while he was researching their products' use in patients, according to records obtained by congressional investigators.

2009-05-28 | CBS TV

Invisble Illness Causes Chronic Pain

BALTIMORE (WJZ)--It's called the invisible illness because people who have it don't look sick. Imagine living with pain every day of your life but having doctors tell you there's nothing wrong.

2009-05-27 | redOrbit

The Evolution Of Migraine From Episodic Headache To Chronic Disorder

Patients living with migraine have strong reason for new optimism concerning a positive future. Two review articles and an accompanying editorial, "The Future of Migraine: Beyond Just Another Pill," in the current issue of Mayo Clinic Proceedings, are the basis for an ironic premise.

2009-05-26 | Medpage Today

Combo Treatment Relieves Comorbid Pain and Depression

Reviewed by Zalman S. Agus, MD; Emeritus Professor University of Pennsylvania School of Medicine. SAN FRANCISCO, May 26 -- A two-pronged intervention of optimized antidepressant and behavioral pain management therapy improves symptoms of comorbid pain and depression, a randomized trial showed.